NEW YORK, January 2, 2026, 17:51 ET — After-hours
- CoreWeave shares were last up 10.8% after the bell following an SEC filing on changes to a key credit facility.
- The filing showed the company lowered a minimum liquidity requirement and delayed the first testing dates for two lender ratios.
- Traders are now watching the company’s coming annual report filing for more detail on covenant headroom and liquidity.
CoreWeave shares rose in after-hours trading on Friday after the AI cloud provider disclosed amendments to a key credit agreement that loosen near-term covenant requirements, a filing showed. The stock was last up 10.8% at $79.32.
The changes matter now because investors have been focused on how quickly heavily financed AI infrastructure companies can turn equipment deliveries into revenue and cash. Covenant tweaks can reduce the risk of a technical breach if project timing shifts.
CoreWeave’s filing tied the amendment directly to delivery timing, underscoring that lenders — and shareholders — are watching whether capacity comes online when expected. Any slippage can cascade into funding needs and cash buffers.
CoreWeave said its subsidiary CoreWeave Compute Acquisition Co. VII, along with the parent company and CCAC VII Holdco, entered into a “First Amendment” on Dec. 31 to amend a DDTL 3.0 credit agreement dated July 28, 2025. MUFG Bank is listed as administrative agent, with U.S. Bank entities in collateral and depository roles, the filing showed.
CoreWeave said the amendment “aligns the facility for the timing of deliveries described” on its earnings call for the quarter ended Sept. 30, 2025. A delayed-draw term loan is a committed facility that can be borrowed in stages, often to match equipment deliveries rather than taking all the cash up front.
The filing said the changes include reducing the minimum liquidity requirement — essentially a minimum cash-and-available-funds buffer — to $100 million for monthly payment dates on and after March 1, 2026 and before May 1, 2026.
CoreWeave also postponed the initial testing date of the debt service coverage ratio covenant to Oct. 31, 2027, and delayed the first test of a contract realization ratio covenant to Feb. 28, 2026, the filing showed. The debt service coverage ratio is a common lender metric that compares cash flow to debt payments.
The amendment allows an unlimited number of “equity cures” — capital injections that help a borrower satisfy a financial covenant — for those ratios until Oct. 28, 2026, and then restricts their use to no more than three consecutive months in any four-month period, the filing said. CoreWeave also said a copy of the amendment will be filed as an exhibit to its annual report on Form 10-K for the year ended Dec. 31, 2025.
CoreWeave stock swung between $72.95 and $81.11 during Friday’s session and logged nearly 30 million shares in volume, market data showed. The stock opened at $73.90.
The covenant relief comes as CoreWeave continues to fund rapid buildouts with debt, leaving investors sensitive to any signals about liquidity headroom. In a separate December filing, CoreWeave said it completed a private offering of $2.5875 billion of 1.75% convertible senior notes due 2031.
Convertible notes are debt that can convert into shares, potentially diluting shareholders if the stock trades above the conversion price. They can also be attractive to issuers because coupon rates are typically lower than on straight high-yield debt.
Investors will now look for the Form 10-K exhibit and any updated disclosure around liquidity and covenant capacity, and whether delivery timing remains on track. CoreWeave has not announced the date for its next earnings report, but market calendars list an estimated reporting date around Feb. 9.
CoreWeave, founded in 2017, listed on Nasdaq in March 2025 and sells cloud computing capacity geared to artificial intelligence workloads. For traders, the next test is whether financing flexibility translates into steadier execution as the company ramps infrastructure.
